Evidence map›Paper›PMID 35627268›Full record

ArticleGenes2022

Genome-Wide Gene Expression Profiling Defines the Mechanism of Anticancer Effect of Colorectal Cancer Cell-Derived Conditioned Medium on Acute Myeloid Leukemia.

Ji-Eun Lee, Chan-Seong Kwon, Byeol-Eun Jeon, Woo Ryung Kim, Du Hyeong Lee, Sara Koh, Heui-Soo Kim, Sang-Woo Kim

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Norchelerythrine fromInternational journal of oncology · 2025
    Article
  2. Therapeutic Potential ofInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Anti-Leukemic Effects ofCurrent issues in molecular biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ji-Eun LeeDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
Chan-Seong KwonDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
Byeol-Eun JeonDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
Woo Ryung KimDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
Du Hyeong LeeDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
Sara KohDepartment of Biological Sciences, Southern Methodist University, Dallas, TX 75206, USA.
Heui-Soo KimDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
Sang-Woo KimDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea.
Pusan National University · KRSouthern Methodist University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) is the most common type of leukemia in adults, accounting for 30% of all adult leukemia cases. While there have been recent improvements in the prognosis of the disease, the prognosis remains grim, and further understanding of AML and the development of new therapeutic agents is critical. This study aimed to investigate the potential interaction between colorectal cancer (CRC) cells and AML cells. Unexpectedly, we found that CRC cell-derived conditioned medium (CM) showed anticancer activities in AML cells by inducing apoptosis and differentiation. Mechanistic studies suggest that these phenotypes are closely associated with the suppression of PI3K/AKT/mTOR and MAPK survival signaling, the upregulation of myeloid differentiation-promoting transcription factors

Indexed as

Colorectal NeoplasmsLeukemia, Myeloid, AcuteCulture Media, ConditionedGene Expression ProfilingHumansPhosphatidylinositol 3-KinasesSignal TransductionCulture Media, ConditionedPhosphatidylinositol 3-Kinasesacute myeloid leukemia (AML)anticancer effectconditioned mediumgene expression profiling

Identifiers

PMID35627268
PMCPMC9171579
OpenAlexW4280597194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.